FDA Approves First Blood Test for Alzheimer’s Disease Detection
The FDA cleared Lumipulse, a blood test by Fujirebio Diagnostics, which detects amyloid beta plaques – a key Alzheimer’s marker – by measuring proteins p-Tau217 and beta-amyloid 1-42. This offers a faster, cheaper and more accessible alternative to PET scans or spinal taps. Current methods (PET scans and spinal taps) are costly and invasive, often …
FDA Approves First Blood Test for Alzheimer’s Disease Detection Read More »